Biologic AI is a biotechnology company that uses an AI-powered discovery platform to computationally design novel, patent-protected peptides that target the root molecular drivers of skin aging.
Biologic AI is a biotechnology company that utilizes an oncology-grade, structure-based artificial intelligence platform to computationally design novel, patent-protected peptides for skin longevity. Its discovery engine is powered by an orchestrated stack of over 40 computational tools, which are calibrated against experimental ground truth to simulate the entire validation process from target to filed intellectual property in silico, minimizing the need for initial laboratory expenditure.
By prioritizing computational discovery over traditional lab-first screening, the company develops mechanism-specific actives aimed at targeting the root molecular drivers of skin aging. This approach allows Biologic AI to generate a pipeline of proprietary compounds that can either be licensed or utilized to develop science-first, owned brands, offering a novel category of solutions in the skin health and beauty sectors.